8th COVID-19 Vaccine Authorized by the U.K.

S.K. Chemicals' SKYCovion COVID-19 vaccine has been authorized by the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA).

This authorization is for use as a primary vaccination in those aged 18 and over. Decisions on which COVID-19 vaccines are deployed in the U.K. are taken by the Joint Committee on Vaccination and Immunisation.

As of May 26, 2023, it becomes the 8th COVID-19 vaccine authorized by the U.K.

The SKYCovion vaccine combines a part of the SARS-CoV-2 virus spike protein with an 'adjuvant' – an additional ingredient designed to trigger a more robust immune response. It is given as two injections, four weeks apart.